Your browser doesn't support javascript.
loading
Montrer: 20 | 50 | 100
Résultats 1 - 4 de 4
Filtre
1.
Clinics ; 70(3): 169-172, 03/2015. tab
Article Dans Anglais | LILACS | ID: lil-747107

Résumé

BACKGROUND: To evaluate the macrophage migration inhibitory factor and E-selectin levels in patients with acute coronary syndrome. MATERIALS/METHODS: We examined the plasma migration inhibitory factor and E-selectin levels in 87 patients who presented with chest pain at our hospital. The patients were classified into two groups according to their cardiac status. Sixty-five patients had acute myocardial infarction, and 22 patients had non-cardiac chest pain (non-coronary disease). We designated the latter group of patients as the control group. The patients who presented with acute myocardial infarction were further divided into two subgroups: ST-elevated myocardial infarction (n = 30) and non-ST elevated myocardial infarction (n = 35). RESULTS: We found higher plasma migration inhibitory factor levels in both acute myocardial infarction subgroups than in the control group. However, the E-selectin levels were similar between the acute myocardial infarction and control patients. In addition, we did not find a significant difference in the plasma migration inhibitory factor levels between the ST elevated myocardial infarction and NST-elevated myocardial infarction subgroups. DISCUSSION: The circulating concentrations of migration inhibitory factor were significantly increased in acute myocardial infarction patients, whereas the soluble E-selectin levels were similar between acute myocardial infarction patients and control subjects. Our results suggest that migration inhibitory factor may play a role in the atherosclerotic process. .


Sujets)
Animaux , Femelle , Souris , /métabolisme , Interféron gamma/métabolisme , Tumeurs mammaires de l'animal/immunologie , Sphéroïdes de cellules/immunologie , Lymphocytes T cytotoxiques/métabolisme , Lymphocytes T auxiliaires/métabolisme , Alginates , Antigènes néoplasiques/immunologie , Antigènes néoplasiques/métabolisme , Lignée cellulaire tumorale , Mouvement cellulaire , Chitosane , /génétique , /immunologie , Acide glucuronique , Granzymes/métabolisme , Acides hexuroniques , Immunité cellulaire , Interféron gamma/génétique , Interféron gamma/immunologie , Tumeurs mammaires de l'animal/génétique , Tumeurs mammaires de l'animal/métabolisme , Tumeurs mammaires de l'animal/anatomopathologie , Sphéroïdes de cellules/métabolisme , Sphéroïdes de cellules/anatomopathologie , Lymphocytes T cytotoxiques/immunologie , Lymphocytes T auxiliaires/immunologie , Microenvironnement tumoral
2.
Journal of Veterinary Science ; : 39-42, 2012.
Article Dans Anglais | WPRIM | ID: wpr-13094

Résumé

The aim of this study was to evaluate prognostic and/or diagnostic factors of canine mammary tumors by immunohistochemically analyzing the expression of alpha basic crystallin (alphaB-c). For this, formalin-fixed, paraffin-embedded blocks of 51 naturally-occurring canine mammary tumors (11 benign and 40 malignant) were used. Tissue from eight normal canine mammary glands were served as a control. Immunohistochemically, in the control mammary tissues, a few luminal epithelial cells were alphaB-c positive but myoepithelial cells were negative. In benign or simple type malignant tumors, alphaB-c expression was observed in luminal epithelial cells while the myoepithelial basal cells were negative. In benign or complex type malign tumors, positive staining was predominantly found in the cytoplasm of epithelial cells. Immunoreactivity of alphaB-c was also observed in neoplastic myoepithelial cells. Statistically, the number of cells immunolabeled with alphaB-c was found to be significantly different among tissues from normal canine mammary glands, benign lesions, and malignant tumors (p < 0.05). alphaB-c immunoreactivity was higher in malignant tumors than the control mammary tissues (p < 0.001). Data obtained in the current study revealed a strong association between high expression levels of alphaB-c and primary mammary gland tumors in canines.


Sujets)
Animaux , Chiens , Femelle , Maladies des chiens/métabolisme , Immunohistochimie/médecine vétérinaire , Modèles logistiques , Tumeurs mammaires de l'animal/métabolisme , Cristallines alpha/biosynthèse
3.
Indian J Biochem Biophys ; 2007 Jun; 44(3): 145-51
Article Dans Anglais | IMSEAR | ID: sea-28087

Résumé

Malignant transformation is associated with changes in the glycosylation of cell surface proteins and lipids. In tumor cells, alterations in cellular glycosylation may play a key role in their metastatic behaviour. In the present study, we have assessed the relationship between cell surface oligosaccharides and the metastasis ability of mouse mammary tumor cell lines 67NR and 4TO7. The cell surface oligosaccharides have been analyzed using specific binding assays with some plant lectins and the metastasis ability has been studied using transwell migration and invasion assays. In addition, we investigated the role of terminal sialic acids in the metastatic potential (cell adhesion on fibronectin, cell migration and invasion) in the 4TO7 cells on treatment with neuraminidase. The cell lines used in study have different metastasis abilities in vivo - the 67NR form primary tumors, but no tumor cells are detectable in any distant tissues, while cells of the 4TO7 line are able to spread to lung. In vitro metastasis experiments have revealed higher ability of adhesion, cell migration and invasion in the 4TO7 cells than the 67NR cells. Specific lectins binding assays show that the 4TO7 cells expressed more high-mannose type, multi-antennary complex-type N-glycans, beta-1,6-GlcNAc-branching, alpha-2,6-linked sialic acids, N-acetylgalactosamine and galactosyl(beta-1,3)-N-acetylgalactosamine. Removal of sialic acids on treatment with neuraminidase decreases adhesion, but increases the migration and has shown no significant change in the invasion ability of the 4TO7 cells. The study suggests that the sialic acids are not crucial for the cell migration and invasion in the 4TO7 cells. The findings provide the new insights in understanding the role of cell surface oligosaccharides in cancer metastasis.


Sujets)
Animaux , Adhérence cellulaire , Lignée cellulaire tumorale , Membrane cellulaire/métabolisme , Mouvement cellulaire , Cellules , Glycosylation , Lectines/composition chimique , Tumeurs mammaires de l'animal/métabolisme , Souris , Invasion tumorale , Métastase tumorale , Oligosaccharides/composition chimique , Polyosides/composition chimique , Acides sialiques/composition chimique
4.
Medicina (B.Aires) ; 56(supl.1): 32-44, 1996. ilus, tab
Article Dans Espagnol | LILACS | ID: lil-187354

Résumé

Durante el crecimiento de los tumores el papel del sistema inmune es controvertido, y a pesar de las grandes expectativas en poder estimularlo para que fuera eficiente en el rechazo de los mismos, este objetivo aún no se ha cumplido. En este revisión se resumen y se analizan los estudios inmunológicos realizados con modelos de tumores murinos en nuestro laboratorio. Nosotros hemos trabajado con tumores de mama murinos, y en nuestros primeros estudios hemos determinado que el sistema inmune de los portadores de tumor durante las primeras etapas de su evolución reconoce en forma específica los antígenos tumorales, y que sus linfocitos están activados para respuestas de hipersensibilidad retardada in vivo e in vitro y angiogénesis linfocitaria. Sin embargo, esta funcionalidad no se correlaciona con los mecanismos efectores de rechazo tumoral. El reconocimiento y activación linfocitarias desaparecem a medida que tumor crece. Las células tumorales y linfocitos del portador de tumor secretan factores solubles que exacerban el crecimiento tumoral y metastásico. Las poblaciones de neutrófilos y mastocitos también se encuentran alteradas durante el crecimiento del tumor. Postulamos que las células tumorales secretan factores que inducen poblaciones celulares a producir inmunosupresores que favorecem el desarrollo del mismo tumor.


Sujets)
Animaux , Souris , Tumeurs mammaires de l'animal/immunologie , Antigènes néoplasiques , Tumeurs mammaires de l'animal/métabolisme , Tumeurs mammaires de l'animal/anatomopathologie
SÉLECTION CITATIONS
Détails de la recherche